Newer Direct-Acting Anti-Viral Agents as Sole Therapy of Porphyria Cutanea Tarda in Subjects With Chronic Hepatitis C
Phase of Trial: Phase II
Latest Information Update: 22 Feb 2018
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C; Porphyria cutanea tarda
- Focus Therapeutic Use
- 11 Aug 2017 Status changed from not yet recruiting to recruiting.
- 19 Jul 2017 Planned initiation date changed from 20 May 2017 to 1 Aug 2017.
- 21 Apr 2017 New trial record